189 related articles for article (PubMed ID: 25344584)
1. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.
Mardilovich K; Gabrielsen M; McGarry L; Orange C; Patel R; Shanks E; Edwards J; Olson MF
Mol Cancer Ther; 2015 Jan; 14(1):246-58. PubMed ID: 25344584
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
[TBL] [Abstract][Full Text] [Related]
3. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
[TBL] [Abstract][Full Text] [Related]
4. Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells.
Djamai H; Berrou J; Dupont M; Kaci A; Ehlert JE; Weber H; Baruchel A; Paublant F; Prudent R; Gardin C; Dombret H; Braun T
Leuk Res; 2021 Jan; 100():106490. PubMed ID: 33373830
[TBL] [Abstract][Full Text] [Related]
5. Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer.
Dalal K; Ban F; Li H; Morin H; Roshan-Moniri M; Tam KJ; Shepherd A; Sharma A; Peacock J; Carlson ML; LeBlanc E; Perez C; Duong F; Ong CJ; Rennie PS; Cherkasov A
Cancer Lett; 2018 Nov; 437():35-43. PubMed ID: 30165195
[TBL] [Abstract][Full Text] [Related]
6. LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation.
Mardilovich K; Baugh M; Crighton D; Kowalczyk D; Gabrielsen M; Munro J; Croft DR; Lourenco F; James D; Kalna G; McGarry L; Rath O; Shanks E; Garnett MJ; McDermott U; Brookfield J; Charles M; Hammonds T; Olson MF
Oncotarget; 2015 Nov; 6(36):38469-86. PubMed ID: 26540348
[TBL] [Abstract][Full Text] [Related]
7. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
8. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
Cherian MT; Wilson EM; Shapiro DJ
J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
[TBL] [Abstract][Full Text] [Related]
9. LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.
Li R; Doherty J; Antonipillai J; Chen S; Devlin M; Visser K; Baell J; Street I; Anderson RL; Bernard O
Clin Exp Metastasis; 2013 Apr; 30(4):483-95. PubMed ID: 23239465
[TBL] [Abstract][Full Text] [Related]
10. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.
Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D
PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715
[TBL] [Abstract][Full Text] [Related]
11. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression.
McConnell BV; Koto K; Gutierrez-Hartmann A
Mol Cancer; 2011 Jun; 10():75. PubMed ID: 21682918
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.
Yu Q; Gratzke C; Wang Y; Herlemann A; Sterr CM; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Stief CG; Hennenberg M
Br J Pharmacol; 2018 Jun; 175(11):2077-2096. PubMed ID: 29574791
[TBL] [Abstract][Full Text] [Related]
13. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H
Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of androgen receptor and β-catenin activity in prostate cancer.
Lee E; Madar A; David G; Garabedian MJ; Dasgupta R; Logan SK
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15710-5. PubMed ID: 24019458
[TBL] [Abstract][Full Text] [Related]
15. Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis.
Gu Y; Xue M; Wang Q; Hong X; Wang X; Zhou F; Sun J; Wang G; Peng Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948018
[No Abstract] [Full Text] [Related]
16. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer.
Zhu ML; Horbinski CM; Garzotto M; Qian DZ; Beer TM; Kyprianou N
Cancer Res; 2010 Oct; 70(20):7992-8002. PubMed ID: 20807808
[TBL] [Abstract][Full Text] [Related]
17. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
18. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
[TBL] [Abstract][Full Text] [Related]
19. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
20. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
